Medical management of heavy menstrual bleeding
Women with benign heavy menstrual bleeding have the choice of a number of medical treatment options to reduce their blood loss and improve quality of life. The role of the clinician is to provide information to facilitate women in making an appropriate choice. Unfortunately, many options can be asso...
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Future Medicine Ltd
2016
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728737/ |
| id |
pubmed-4728737 |
|---|---|
| recordtype |
oai_dc |
| spelling |
pubmed-47287372016-01-27 Medical management of heavy menstrual bleeding Maybin, Jacqueline A Critchley, Hilary OD Special Report Women with benign heavy menstrual bleeding have the choice of a number of medical treatment options to reduce their blood loss and improve quality of life. The role of the clinician is to provide information to facilitate women in making an appropriate choice. Unfortunately, many options can be associated with hormonal side effects, prevention of fertility and lack of efficacy, leading to discontinuation and progression to surgical interventions. Herein, we discuss the various options currently available to women, including antifibrinolytics, nonsteroidal anti-inflammatory preparations, oral contraceptive pills and oral, injectable and intrauterine progestogens. In addition, we describe the more novel option of selective progesterone receptor modulators and their current benefits and limitations. Future Medicine Ltd 2016-01 /pmc/articles/PMC4728737/ /pubmed/26695687 http://dx.doi.org/10.2217/whe.15.100 Text en © Hilary OD Critchley This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License (http://creativecommons.org/licenses/by-nc-nd/4.0/) |
| repository_type |
Open Access Journal |
| institution_category |
Foreign Institution |
| institution |
US National Center for Biotechnology Information |
| building |
NCBI PubMed |
| collection |
Online Access |
| language |
English |
| format |
Online |
| author |
Maybin, Jacqueline A Critchley, Hilary OD |
| spellingShingle |
Maybin, Jacqueline A Critchley, Hilary OD Medical management of heavy menstrual bleeding |
| author_facet |
Maybin, Jacqueline A Critchley, Hilary OD |
| author_sort |
Maybin, Jacqueline A |
| title |
Medical management of heavy menstrual bleeding |
| title_short |
Medical management of heavy menstrual bleeding |
| title_full |
Medical management of heavy menstrual bleeding |
| title_fullStr |
Medical management of heavy menstrual bleeding |
| title_full_unstemmed |
Medical management of heavy menstrual bleeding |
| title_sort |
medical management of heavy menstrual bleeding |
| description |
Women with benign heavy menstrual bleeding have the choice of a number of medical treatment options to reduce their blood loss and improve quality of life. The role of the clinician is to provide information to facilitate women in making an appropriate choice. Unfortunately, many options can be associated with hormonal side effects, prevention of fertility and lack of efficacy, leading to discontinuation and progression to surgical interventions. Herein, we discuss the various options currently available to women, including antifibrinolytics, nonsteroidal anti-inflammatory preparations, oral contraceptive pills and oral, injectable and intrauterine progestogens. In addition, we describe the more novel option of selective progesterone receptor modulators and their current benefits and limitations. |
| publisher |
Future Medicine Ltd |
| publishDate |
2016 |
| url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728737/ |
| _version_ |
1613529136643440640 |